Ghazwan Butrous, MB, ChB, PhD
Pulmonary Vascular Research Institute
Canterbury, United Kingdom
Sebastien Bonnet, PhD
Associate Professor of Medicine
Quebec City, Canada
Mourad Toporsian, PhD
Instructor in Medicine
Harvard Medical School
Beth Israel Deaconess Medical Center
29 May 2013
29 May 2015
This activity has been planned and implemented in accordance with the essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of ProCE, Inc., the National Association of Managed Care Physicians (NAMCP), and the Pulmonary Hypertension Association (PHA). The NAMCP is accredited by the ACCME to provide continuing medical education (CME) to physicians. The NAMCP designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
This activity is a self-study program. Upon entering the activity, participants should read the text, examine any images and/or multimedia features, and review the content presented within all of the links provided. Once the course has been reviewed in its entirety, participants will be asked to complete a post-test and evaluation online. Participants must receive a test score of 80% in order to proceed to the course evaluation; the post-test can be repeated until all questions are answered correctly. All evaluation questions must be completed in order to receive a certificate of credit. If needed, participants may save their answers and complete the course at a later date. Saved courses can be found on the "My Activities" page, accessed via "My Account" at the top of the page.
It is the policy of ProCE to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer of any commercial product(s) discussed in an educational presentation.
Ghazwan Butrous, MB, ChB, PhD, indicates that he has served as a consultant or as part of a speaker bureau for Novartis and Bayer and is a stock shareholder with Pfizer.
Mourad Toporsian, PhD, indicates that he has no significant financial interest or any other relationship to disclose.
Sebastien Bonnet, PhD, indicates that he has no significant financial interest or any other relationship to disclose.
The opinions expressed in this program should not be construed as those of the CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this program may include the use of drugs for unlabeled indications. Use of drugs outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
No portion of this activity may be reproduced without the expressed written consent of PHA.
This activity is made possible through unrestricted educational grants from Actelion, Gilead, United Therapeutics and Bayer.
©2015 Pulmonary Hypertension Association, 801 Roeder Road, Suite 1000, Silver Spring, MD 21910.